122 related articles for article (PubMed ID: 18630260)
21. Cyanovirin-N potently inhibits human immunodeficiency virus type 1 infection in cellular and cervical explant models.
Buffa V; Stieh D; Mamhood N; Hu Q; Fletcher P; Shattock RJ
J Gen Virol; 2009 Jan; 90(Pt 1):234-43. PubMed ID: 19088294
[TBL] [Abstract][Full Text] [Related]
22. Fullerene Derivatives Strongly Inhibit HIV-1 Replication by Affecting Virus Maturation without Impairing Protease Activity.
Martinez ZS; Castro E; Seong CS; Cerón MR; Echegoyen L; Llano M
Antimicrob Agents Chemother; 2016 Oct; 60(10):5731-41. PubMed ID: 27431232
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, anti-HIV-1 activity, and modeling studies of N-3 Boc TSAO compound.
Tomassi C; Nguyen VN; Marco-Contelles J; Balzarini J; Pannecouque C; De Clercq E; Soriano E; Postel D
Bioorg Med Chem Lett; 2008 Apr; 18(7):2277-81. PubMed ID: 18353641
[TBL] [Abstract][Full Text] [Related]
24. High-throughput screening of HCV RNA replication inhibitors by means of a reporter replicon system.
Hao W; Duggal R
Methods Mol Biol; 2009; 510():243-50. PubMed ID: 19009266
[TBL] [Abstract][Full Text] [Related]
25. Polysulfated sialic acid derivatives as anti-human immunodeficiency virus.
Terada M; Fujita S; Suda I; Mastico R
Biomed Pharmacother; 2005 Sep; 59(8):423-9. PubMed ID: 16143490
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of human immunodeficiency virus type 1 replication by blocking IkappaB kinase with noraristeromycin.
Asamitsu K; Yamaguchi T; Nakata K; Hibi Y; Victoriano AF; Imai K; Onozaki K; Kitade Y; Okamoto T
J Biochem; 2008 Nov; 144(5):581-9. PubMed ID: 18713798
[TBL] [Abstract][Full Text] [Related]
27. HIV-1 replication is stimulated by sodium stibogluconate, the therapeutic mainstay in the treatment of leishmaniasis.
Barat C; Zhao C; Ouellette M; Tremblay MJ
J Infect Dis; 2007 Jan; 195(2):236-45. PubMed ID: 17191169
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of intracellular hepatitis C virus replication by nelfinavir and synergistic effect with interferon-alpha.
Toma S; Yamashiro T; Arakaki S; Shiroma J; Maeshiro T; Hibiya K; Sakamoto N; Kinjo F; Tateyama M; Fujita J
J Viral Hepat; 2009 Jul; 16(7):506-12. PubMed ID: 19302339
[TBL] [Abstract][Full Text] [Related]
29. Tetrazolium-based colorimetric assay for the detection of HIV replication inhibitors: revisited 20 years later.
Pannecouque C; Daelemans D; De Clercq E
Nat Protoc; 2008; 3(3):427-34. PubMed ID: 18323814
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and anti-HIV activity evaluation of novel 2,4-disubstituted 7-methyl-1,1,3-trioxo-2,4-dihydro-pyrazolo-[4,5-e][1,2]thiadiazines.
Liu XY; Yan RZ; Wang Y; Zhan P; De Clercq E; Pannecouque C; Witvrouw M; Molina MT; Vega S
Arch Pharm (Weinheim); 2008 Apr; 341(4):216-22. PubMed ID: 18266290
[TBL] [Abstract][Full Text] [Related]
31. A novel heme-containing protein with anti-HIV-1 activity from skin secretions of Bufo andrewsi.
Zhao Y; Jin Y; Wang JH; Wang RR; Yang LM; Lee WH; Zheng YT; Zhang Y
Toxicon; 2005 Nov; 46(6):619-24. PubMed ID: 16157359
[TBL] [Abstract][Full Text] [Related]
32. Hydroxyurea, a potential new anti-HIV agent.
Torres G
GMHC Treat Issues; 1995 Jan; 9(1):7-9. PubMed ID: 11367381
[TBL] [Abstract][Full Text] [Related]
33. Anti-HIV activity of some synthetic lignanolides and intermediates.
Sancho R; Medarde M; Sánchez-Palomino S; Madrigal BM; Alcamí J; Muñoz E; San Feliciano A
Bioorg Med Chem Lett; 2004 Sep; 14(17):4483-6. PubMed ID: 15357976
[TBL] [Abstract][Full Text] [Related]
34. High throughput drug screening for human immunodeficiency virus type 1 reactivating compounds.
Jones J; Rodgers J; Heil M; May J; White L; Maddry JA; Fletcher TM; Shaw GM; Hartman JL; Kutsch O
Assay Drug Dev Technol; 2007 Apr; 5(2):181-89. PubMed ID: 17477827
[TBL] [Abstract][Full Text] [Related]
35. Identification of the P-TEFb complex-interacting domain of Brd4 as an inhibitor of HIV-1 replication by functional cDNA library screening in MT-4 cells.
Urano E; Kariya Y; Futahashi Y; Ichikawa R; Hamatake M; Fukazawa H; Morikawa Y; Yoshida T; Koyanagi Y; Yamamoto N; Komano J
FEBS Lett; 2008 Dec; 582(29):4053-8. PubMed ID: 18996376
[TBL] [Abstract][Full Text] [Related]
36. 1,2,3-Selenadiazole thioacetanilides: synthesis and anti-HIV activity evaluation.
Zhan P; Liu X; Fang Z; Pannecouque C; De Clercq E
Bioorg Med Chem; 2009 Sep; 17(17):6374-9. PubMed ID: 19647440
[TBL] [Abstract][Full Text] [Related]
37. A cell-based bicistronic lentiviral reporter system for identification of inhibitors of the hepatitis C virus internal ribosome entry site.
Lourenço S; Boni S; Furling D; Cosset FL; Cahour A
J Virol Methods; 2009 Jun; 158(1-2):152-9. PubMed ID: 19428584
[TBL] [Abstract][Full Text] [Related]
38. The Spirocyclic Imine from a Marine Benthic Dinoflagellate, Portimine, Is a Potent Anti-Human Immunodeficiency Virus Type 1 Therapeutic Lead Compound.
Izumida M; Suga K; Ishibashi F; Kubo Y
Mar Drugs; 2019 Aug; 17(9):. PubMed ID: 31450557
[TBL] [Abstract][Full Text] [Related]
39. Cell-based and biochemical screening approaches for the discovery of novel HIV-1 inhibitors.
Westby M; Nakayama GR; Butler SL; Blair WS
Antiviral Res; 2005 Sep; 67(3):121-40. PubMed ID: 16112209
[TBL] [Abstract][Full Text] [Related]
40. Sustained and specific in vitro inhibition of HIV-1 replication by a protease inhibitor encapsulated in gp120-targeted liposomes.
Clayton R; Ohagen A; Nicol F; Del Vecchio AM; Jonckers TH; Goethals O; Van Loock M; Michiels L; Grigsby J; Xu Z; Zhang YP; Gutshall LL; Cunningham M; Jiang H; Bola S; Sarisky RT; Hertogs K
Antiviral Res; 2009 Nov; 84(2):142-9. PubMed ID: 19699239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
